Overview
Minqi Xu practices practicing medicine in Kingston, Canada.
Their clinical expertise encompasses Pulmonary Nocardiosis, Nocardiosis, Bladder Cancer, and Urothelial Cancer.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Minqi Xu
Is Minqi Xu a top-rated expert for Pulmonary Nocardiosis?
MediFind is an objective health platform that identifies experts based on real-world data. Minqi Xu is classified as an Experienced expert for Pulmonary Nocardiosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Minqi Xu participate in research or clinical trials?
Yes. Minqi Xu has published 8 articles and abstracts on conditions like Pulmonary Nocardiosis. You can view a list of Minqi Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerXu isExperienced. Learn about Bladder Cancer.
- NocardiosisXu isExperienced. Learn about Nocardiosis.
- Non-Muscle Invasive Bladder Cancer
- Pulmonary NocardiosisXu isExperienced. Learn about Pulmonary Nocardiosis.
- Urothelial CancerXu isExperienced. Learn about Urothelial Cancer.